Home > Specialists > Obstetrics & Gynecology > Dr. Fei Chen (陈飞)

Specialty & Clinical Focus:
Beijing-based gynecologist at Peking Union Medical College Hospital (PUMCH), focused on cervical pathology, HPV management and screening, abnormal cervical screening results, colposcopy, LEEP, and lower genital tract precancerous lesions.
Professional Title & Qualifications:
Chief Physician,
Professor,
M.D.
Hospital & Department:
Peking Union Medical College Hospital (PUMCH) – Department of Gynecology
(Note: PUMCH is consistently ranked as the #1 hospital in China)
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Fei Chen (陈飞) - Gynecological Specialist
Personal Biography
Dr. Fei Chen is a Chief Physician, Professor and M.D. in the Department of Obstetrics and Gynecology at Peking Union Medical College Hospital (PUMCH) in Beijing. Her clinical work focuses on cervical pathology, HPV management and screening, including abnormal cervical screening results, colposcopy, and lower genital tract precancerous lesions. She serves as Head of the Cervical Cancer Screening Training Base at PUMCH, has been honored as a “Good Doctor of the Year,” and has contributed to more than 20 national guidelines and expert consensuses in gynecology and cervical disease.
MedBridgeNZ Insight: Why Choose Dr. Chen?
Patients considering Dr. Fei Chen often need a careful review of cervical screening results, HPV reports, pathology documents, colposcopy findings or prior treatment records. Her PUMCH gynecology background and cervical cancer screening leadership make her a highly relevant specialist for international patients seeking organized pre-travel review before deciding whether to pursue an in-person pathway in Beijing.
For this type of case, clear translation, chronology, prior test results and a focused question list can make the specialist review process more structured and useful, especially when the patient is comparing next-step options before medical travel to China.
Pre-Travel Case Review & Specialist Liaison
Before committing to medical travel to Beijing, international patients can request MedBridgeNZ coordination for a remote specialist-review pathway with Dr. Fei Chen where available. Our team prepares the case file, coordinates medical-record translation, organizes key questions, and manages client-authorized document transfer and appointment-request communication with the relevant hospital or specialist office.
This pre-travel process helps submitted records enter the appropriate gynecology review pathway for appointment triage or preliminary specialist opinion before the patient plans flights, accommodation and an in-person visit to China.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Fei Chen
Areas of Expertise
HPV Vaccination & Consultation: Expert guidance on vaccination protocols and related inquiries.
Cervical Cancer Screening Management: Comprehensive management of abnormal screening results, including TCT (ThinPrep Cytologic Test) and HPV abnormalities.
Colposcopy & Pathology: Advanced diagnosis using colposcopy for cervical, vaginal, and vulvar lesions, utilizing techniques from her translated work "Colposcopy".
Surgical Interventions: Specializes in LEEP (Loop Electrosurgical Excision Procedure) and the management of lower genital tract inflammation and precancerous lesions.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 4.8/5.0 Overall Rating
* Treatment Pathway Satisfaction:
4.6/5.0
* Communication & Professionalism:
4.9/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
15,100 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Education & Training
Awards & Honors
Honored as a "Good Doctor of the Year" for two sessions.
Academic & Professional Memberships
Head: Cervical Cancer Screening Training Base, Peking Union Medical College Hospital.
Standing Committee Member: Cervical Cancer Screening Professional Committee, National Cancer Center.
President: Reproductive Health Branch of the China Association for the Promotion of Population Culture (CRTHA).
Deputy Head: Cervical Lesion Group, Obstetrics and Gynecology Branch, Chinese Medical Doctor Association.
Standing Committee Member: China Society for Colposcopy and Cervical Pathology (CSCCP).
Committee Member: Onco-Fertility Group, Family Planning Branch, Chinese Medical Association.
Expert Member: Medical Device Classification Technical Committee, CFDA (National Food and Drug Administration).
Lifelong Visiting Expert: Tibet Autonomous Region People's Hospital.
Research & Publications
Editor-in-Chief: "Blue Book of Cervical Cancer Prevention and Control in China" (Tier 3) and "Practical Colposcopy Techniques" (People's Medical Publishing House).
Lead Translator: "Colposcopy".
Editorial Board: Reviewer and board member for "Chinese Medical Journal," "Chinese Journal of Health Management," and "Journal of Practical Obstetrics and Gynecology".
Guidelines: Led or participated in the development of over 20 relevant guidelines and expert consensuses.
Research Projects: Undertakes and participates in multiple national and municipal scientific research projects.
Published Works: Co-edited/translated works including "Clinical Decision Making in Gynecologic Oncology," "Cervicology," and "Modern Colposcopy".
Selected Peer-Reviewed Publications
Fei C, et al. A real-world multicenter study on opportunistic cervical cancer screening in hospitals in China: comparison of TruScreen device, cytology, and HPV testing for detecting high-grade cervical lesions. BMC Cancer. 2026;26(1):362. PMID: 41634646.
Chen F, et al. Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: a real-world prospective multicenter cohort study. Gynecol Oncol. 2023;178:8-13. PMID: 37734188.
Chen F, et al. Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol. BMJ Open. 2022;12(6):e061740. PMID: 35667715.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Is Dr. Chen’s clinical expertise relevant to my HPV or cervical pathology case?
Dr. Chen’s clinical focus covers cervical pathology, HPV screening management, abnormal TCT/HPV results, colposcopy, LEEP and lower genital tract precancerous lesions. For international patients, MedBridgeNZ can coordinate records preparation and translation so the relevant specialist office can review the submitted materials for appointment triage or preliminary case-screening within the available pathway. This helps clarify whether her stated clinical focus is relevant before you plan medical travel to Beijing.
How can international patients request appointment coordination with Dr. Chen at PUMCH?
Appointment access at PUMCH can be difficult for overseas patients because of local booking workflows, Chinese-language documentation and hospital communication requirements. MedBridgeNZ helps prepare your medical records, translate key documents, organize your questions and coordinate appointment-request communication with the relevant hospital or specialist office. Where a remote specialist-review or pre-travel triage pathway is available, we help your case enter that process before an onsite visit is arranged.
If an in-person visit is recommended, what logistical support is available in Beijing?
If the specialist-review pathway or hospital office indicates that an onsite appointment should be pursued, MedBridgeNZ can assist with non-clinical logistics for medical travel to China. This may include medical invitation or visa-document coordination support, appointment scheduling communication, travel planning, accommodation coordination, medical-record translation coordination and bilingual administrative support during hospital visits where separately arranged.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking gynecology and specialist-care pathways in China. For patients considering Dr. Fei Chen at PUMCH, we help coordinate appointment requests, medical-record preparation, translation coordination, medical invitation or visa-document support, travel planning, accommodation coordination and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis or treatment; third-party hospital, specialist and travel costs remain separate unless expressly stated in writing.
